USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-02-26 обновлены отчеты компании CLDX: 202320222021
Celldex Therapeutics logo
Celldex Therapeutics CLDX
$ 42.56 4.16%

Celldex Therapeutics Мультипликаторы 2011-2024 | CLDX

Мультипликаторы по годам Celldex Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.0 -0.0 -0.0 -0.0 -0.7 -0.4 -3.9 -2.6 -6.3 -16.2 -25.8 -7.1 -4.0

P/S

0.3 0.8 0.3 0.1 9.4 6.7 28.2 48.6 147.0 534.0 512.5 37.5 19.1

EPS

-2.9 -2.4 -1.6 -2.0 -3.5 -14.5 -0.7 -1.3 -1.3 -1.3 -1.0 -1.0 -1.1

EV (Enterprise Value)

3.97 млн -895 тыс. -12.6 млн -16.7 млн 51.2 млн 71.7 млн 399 млн 405 млн 781 млн 1.92 млрд 1.96 млрд 425 млн 195 млн

EBITDA per Share

-3.13 тыс. -2.4 тыс. -1.59 тыс. -2 тыс. -3.42 -7.3 -12.7 -19.5 -19.9 -20.4 -15.1 -14.8 -15.8

EV/EBITDA

0.2 -5.9 -0.4 -0.6 -3.0 -2.2 -5.7 -15.6 -24.1 -7.1 -4.4

PEG

-0.0 -0.0 -0.0 -0.0 -0.01 0.01 -0.09 -0.84 -8.36 0.55 2.7 -0.73 0.0

P/B

0.0 0.0 0.0 0.0 0.4 0.5 1.5 1.2 2.8 9.0 6.6 4.4 2.6

P/CF

-0.0 -0.0 -0.0 -0.0 -0.7 -0.8 -3.5 -2.8 -7.8 -18.5 -29.3 -8.4 -4.9

ROE %

-32.95 -34.43 -16.81 -28.55 -54.11 -121.86 -39.36 -48.42 -43.85 -55.79 -25.50 -61.73 -65.19

ROA %

-30.37 -31.84 -15.86 -25.35 -41.39 -97.03 -29.48 -33.53 -37.68 -47.61 -23.50 -47.09 -45.72

ROCE %

-36.01 -35.33 -16.98 -30.26 -48.99 -53.35 -37.98 -38.18 -42.15 -54.77 -24.93 -53.85 -51.91

Current Ratio

12.8 13.3 17.7 8.9 5.7 7.9 5.2 5.6 9.8 8.4 15.0 4.8 3.8

DSO

78.9 40.2 77.5 69.3 103.7 121.0 53.8 96.0 64.6 43.5 43.4 1.4 6.7

DIO

- - - - - - - - - - - - -

DPO

4157.4 8336.6 4153.7 2027.6 - - - - - - 350.8 25.2 37.4

Операционный цикл

78.9 40.2 77.5 69.3 - - - - - - 43.4 1.4 6.7

Финансовый цикл

-4078.5 -8296.4 -4076.2 -1958.3 - - - - - - -307.4 -23.8 -30.7

Все данные представлены в валюте USD

Мультипликаторы поквартально Celldex Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.81 -0.65 -0.62 - -0.57 -0.77 -0.49 - -0.45 -0.34 -0.42 -0.55 -0.36 -0.5 -0.73 -0.64 -0.75 -0.84 -1.4 -0.81 -0.66 -1.67 -12.61 -0.42 -3.05 -3.42 -4.19 -0.3 -0.29 -0.32 -0.35 -0.33 -0.32 -0.33 -0.33 -0.36 -0.31 -0.32 -0.33 -0.27 -0.29 -0.24 -0.23 -0.27 -0.25 -0.23 -0.27 -0.29 -0.27 -0.27 -0.31

EBITDA per Share

- - -672 - -543 -745 -480 - -0.41 -0.3 -0.4 - -0.28 -0.41 -0.67 - -0.53 -0.7 -1.35 - -0.45 -1.72 -12.7 - -0.22 -0.21 -0.28 - -0.28 -0.31 -0.35 - -0.31 -0.32 -0.33 - -0.32 -0.31 -0.35 - -0.27 -0.22 -0.23 - -0.22 -0.21 -0.25 - -0.22 -0.23 -0.28

ROE %

-43.95 -36.20 -35.07 -23.41 -28.09 -25.02 -22.49 -20.54 -31.00 -33.11 -31.04 -28.55 -29.20 -34.55 -41.81 -54.11 -50.58 -44.28 -44.98 -121.86 -115.91 -121.23 -120.09 -39.36 -49.90 -49.90 -49.85 -48.42 -47.52 -47.39 -46.51 -43.85 -47.61 -49.86 -52.06 -55.79 -47.65 -41.62 -34.21 -25.50 -36.15 -44.60 -53.04 -61.73 -62.71 -64.15 -64.66 -65.19 -17.13 -14.89 -14.64

ROA %

-40.14 -33.75 -32.49 -21.62 -26.07 -23.26 -20.86 -18.53 -27.82 -29.40 -27.54 -25.35 -24.56 -27.81 -32.72 -41.39 -38.92 -34.29 -35.24 -97.03 -92.21 -95.92 -94.44 -29.48 -36.69 -36.05 -35.34 -33.53 -34.78 -36.53 -37.78 -37.68 -40.83 -42.68 -44.49 -47.61 -41.14 -36.48 -30.56 -23.50 -30.53 -35.83 -41.32 -47.09 -46.70 -46.74 -46.22 -45.72 -12.01 -10.45 -10.26

ROCE %

-47.42 -38.73 -36.73 -23.83 -28.60 -25.35 -22.75 -20.71 -27.56 -29.64 -27.70 -18.42 -31.02 -36.77 -44.37 -44.71 -50.97 -44.63 -45.20 -116.33 -129.85 -137.11 -135.75 -40.61 -51.91 -49.69 -49.65 -36.94 -48.10 -47.96 -47.06 -33.13 -47.46 -50.64 -52.84 -42.70 -49.98 -42.92 -35.26 -18.55 -33.95 -42.08 -50.33 -43.36 -60.06 -61.36 -61.66 -45.13 -16.70 -14.38 -14.05

Current Ratio

8.4 13.8 14.9 13.3 15.5 10.6 16.4 17.7 19.6 9.2 8.8 8.9 8.9 8.9 8.9 4.2 4.2 4.2 4.2 4.9 4.9 4.9 4.9 4.0 4.0 4.0 4.0 3.2 3.2 3.2 3.2 7.1 7.1 7.1 7.1 6.8 6.8 6.8 6.8 12.7 12.7 12.7 12.7 4.2 4.2 4.2 4.2 3.4 3.4 3.4 3.4

DSO

11.1 243.8 78.4 - 32.1 95.2 108.8 - 206.7 30.5 241.8 43.4 246.2 696.8 47.1 104.4 169.6 129.5 133.7 163.6 306.6 104.4 56.5 49.6 43.7 44.8 109.0 86.9 73.3 117.2 96.4 49.5 86.3 40.6 131.2 26.4 35.4 65.8 100.5 72.0 45.5 460.0 10.1 1.1 1.3 2.0 4.0 6.4 6.6 8.0 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

11.1 243.8 78.4 - 32.1 95.2 108.8 - 206.7 30.5 241.8 43.4 246.2 696.8 47.1 104.4 169.6 129.5 133.7 163.6 306.6 104.4 56.5 49.6 43.7 44.8 109.0 86.9 73.3 117.2 96.4 49.5 86.3 40.6 131.2 26.4 35.4 65.8 100.5 72.0 45.5 460.0 10.1 1.1 1.3 2.0 4.0 6.4 6.6 8.0 -

Финансовый цикл

11.1 243.8 78.4 - 32.1 95.2 108.8 - 206.7 30.5 241.8 43.4 246.2 696.8 47.1 104.4 169.6 129.5 133.7 163.6 306.6 104.4 56.5 49.6 43.7 44.8 109.0 86.9 73.3 117.2 96.4 49.5 86.3 40.6 131.2 26.4 35.4 65.8 100.5 72.0 45.5 460.0 10.1 1.1 1.3 2.0 4.0 6.4 6.6 8.0 -

Все данные представлены в валюте USD